Biotron Beheer
Beheer criteriumcontroles 4/4
Biotron's CEO is Michelle Miller, appointed in Jun 2002, has a tenure of 22.42 years. total yearly compensation is A$385.35K, comprised of 88.6% salary and 11.4% bonuses, including company stock and options. directly owns 0.42% of the company’s shares, worth A$71.96K. The average tenure of the management team and the board of directors is 22.4 years and 12.7 years respectively.
Belangrijke informatie
Michelle Miller
Algemeen directeur
AU$385.4k
Totale compensatie
| Percentage CEO-salaris | 88.6% |
| Dienstverband CEO | 22.4yrs |
| Eigendom CEO | 0.4% |
| Management gemiddelde ambtstermijn | 22.4yrs |
| Gemiddelde ambtstermijn bestuur | 12.7yrs |
Recente managementupdates
Recent updates
Here's Why We're Not Too Worried About Biotron's (ASX:BIT) Cash Burn Situation
Feb 27
We Think Biotron (ASX:BIT) Can Afford To Drive Business Growth
Oct 20We're Not Worried About Biotron's (ASX:BIT) Cash Burn
Jul 06Will Biotron (ASX:BIT) Spend Its Cash Wisely?
Jan 18Will Biotron (ASX:BIT) Spend Its Cash Wisely?
Jul 06Here's Why We're Watching Biotron's (ASX:BIT) Cash Burn Situation
Mar 17Here's Why We're Not Too Worried About Biotron's (ASX:BIT) Cash Burn Situation
Nov 27Biotron (ASX:BIT) Is In A Good Position To Deliver On Growth Plans
May 26We're Not Very Worried About Biotron's (ASX:BIT) Cash Burn Rate
Feb 10What Can We Conclude About Biotron's (ASX:BIT) CEO Pay?
Dec 19Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | AU$385k | AU$341k | -AU$3m |
| Mar 31 2024 | n/a | n/a | -AU$4m |
| Dec 31 2023 | n/a | n/a | -AU$4m |
| Sep 30 2023 | n/a | n/a | -AU$4m |
| Jun 30 2023 | AU$387k | AU$341k | -AU$3m |
| Mar 31 2023 | n/a | n/a | -AU$3m |
| Dec 31 2022 | n/a | n/a | -AU$2m |
| Sep 30 2022 | n/a | n/a | -AU$2m |
| Jun 30 2022 | AU$380k | AU$329k | -AU$3m |
| Mar 31 2022 | n/a | n/a | -AU$3m |
| Dec 31 2021 | n/a | n/a | -AU$3m |
| Sep 30 2021 | n/a | n/a | -AU$3m |
| Jun 30 2021 | AU$405k | AU$329k | -AU$3m |
| Mar 31 2021 | n/a | n/a | -AU$4m |
| Dec 31 2020 | n/a | n/a | -AU$4m |
| Sep 30 2020 | n/a | n/a | -AU$4m |
| Jun 30 2020 | AU$381k | AU$323k | -AU$4m |
| Mar 31 2020 | n/a | n/a | -AU$3m |
| Dec 31 2019 | n/a | n/a | -AU$3m |
| Sep 30 2019 | n/a | n/a | -AU$3m |
| Jun 30 2019 | AU$351k | AU$307k | -AU$2m |
| Mar 31 2019 | n/a | n/a | -AU$2m |
| Dec 31 2018 | n/a | n/a | -AU$2m |
| Sep 30 2018 | n/a | n/a | -AU$2m |
| Jun 30 2018 | AU$344k | AU$300k | -AU$2m |
Compensatie versus markt: Michelle's total compensation ($USD254.51K) is about average for companies of similar size in the Australian market ($USD299.27K).
Compensatie versus inkomsten: Michelle's compensation has been consistent with company performance over the past year.
CEO
Michelle Miller
22.4yrs
Tenure
AU$385,354
Compensatie
Dr. Michelle Miller, B.Sc., M.Sc., PhD, GCertAppFin (Finsia), serves as Managing Director at Biotron Limited since June 21, 2002 and served as Chief Executive Officer until 2021. Dr. Miller served as Inves...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| MD & Executive Director | 22.4yrs | AU$385.35k | 0.42% A$ 72.0k | |
| Company Secretary | 25.8yrs | AU$120.00k | 0.88% A$ 150.4k | |
| Chief Medical Officer | 4.3yrs | geen gegevens | geen gegevens |
22.4yrs
Gemiddelde duur
Ervaren management: BIT's management team is seasoned and experienced (22.4 years average tenure).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| MD & Executive Director | 22.4yrs | AU$385.35k | 0.42% A$ 72.0k | |
| Independent Non Executive Chairman | 24.8yrs | AU$83.25k | 1.24% A$ 213.1k | |
| Independent & Non-Executive Director | 12.7yrs | AU$44.40k | 0.47% A$ 79.8k | |
| Independent & Non-Executive Director | 12.7yrs | AU$44.40k | 0.087% A$ 14.9k | |
| Independent & Non-Executive Director | 6.1yrs | AU$44.40k | 0.089% A$ 15.2k |
12.7yrs
Gemiddelde duur
Ervaren bestuur: BIT's board of directors are seasoned and experienced ( 12.7 years average tenure).